NO790229L - Fremgangsmaate ved fremstilling av 11beta-hydroxysteroider av pregnanrekken som er substituert i 17-stilling - Google Patents

Fremgangsmaate ved fremstilling av 11beta-hydroxysteroider av pregnanrekken som er substituert i 17-stilling

Info

Publication number
NO790229L
NO790229L NO790229A NO790229A NO790229L NO 790229 L NO790229 L NO 790229L NO 790229 A NO790229 A NO 790229A NO 790229 A NO790229 A NO 790229A NO 790229 L NO790229 L NO 790229L
Authority
NO
Norway
Prior art keywords
hydroxysteroids
11beta
pregnan
procedure
preparation
Prior art date
Application number
NO790229A
Other languages
English (en)
Other versions
NO154583C (no
NO154583B (no
Inventor
Ernst Schoettle
Alfred Weber
Mario Kennecke
Helmut Dahl
Joachim-Friedrich Kapp
Hans Wendt
Klaus Annen
Henry Laurent
Rudolf Wiechert
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19782803661 external-priority patent/DE2803661A1/de
Priority claimed from DE19782855465 external-priority patent/DE2855465A1/de
Application filed by Schering Ag filed Critical Schering Ag
Publication of NO790229L publication Critical patent/NO790229L/no
Publication of NO154583B publication Critical patent/NO154583B/no
Publication of NO154583C publication Critical patent/NO154583C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0053—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa not substituted in position 16
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
    • C07J5/0069—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • C07J5/0076—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
    • C07J5/0069—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • C07J5/0084—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkylene group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/004—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa
    • C07J7/0045—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa not substituted in position 16
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/008—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
    • C07J7/0085—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21 by an halogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes
    • C07J71/0015—Oxiranes at position 9(11)
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/911—Microorganisms using fungi

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO790229A 1978-01-25 1979-01-24 Analogifremgangsmaate ved fremstilling av terapeutisk aktive 17-substitiuerte 11beta-hydroxysteroider av pregnanrekke NO154583C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19782803661 DE2803661A1 (de) 1978-01-25 1978-01-25 Neue in 17-position substituierte 11beta-hydroxysteroide der pregnanreihe, ihre herstellung und verwendung
DE19782855465 DE2855465A1 (de) 1978-12-19 1978-12-19 Neue kortikoide, verfahren zu ihrer herstellung, ihre verwendung und diese kortikoide enthaltende pharmazeutische praeparate

Publications (3)

Publication Number Publication Date
NO790229L true NO790229L (no) 1979-07-26
NO154583B NO154583B (no) 1986-07-28
NO154583C NO154583C (no) 1986-11-05

Family

ID=25773724

Family Applications (1)

Application Number Title Priority Date Filing Date
NO790229A NO154583C (no) 1978-01-25 1979-01-24 Analogifremgangsmaate ved fremstilling av terapeutisk aktive 17-substitiuerte 11beta-hydroxysteroider av pregnanrekke

Country Status (21)

Country Link
US (1) US4207316A (no)
EP (1) EP0003341B1 (no)
AU (1) AU529292B2 (no)
BG (4) BG33735A3 (no)
CS (1) CS207753B2 (no)
DD (2) DD150749A5 (no)
DE (1) DE2967070D1 (no)
DK (1) DK28779A (no)
EG (1) EG14273A (no)
ES (1) ES477162A1 (no)
FI (1) FI66023C (no)
FR (1) FR2422689A1 (no)
GB (1) GB2014150B (no)
IE (1) IE47729B1 (no)
IL (1) IL56494A (no)
NO (1) NO154583C (no)
NZ (1) NZ189460A (no)
PH (1) PH18164A (no)
PT (1) PT69126A (no)
RO (2) RO81116A (no)
SU (6) SU876059A3 (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2952003A1 (de) * 1979-12-21 1981-07-02 Schering Ag Berlin Und Bergkamen, 1000 Berlin Neue kortikoid-17-thioacetale, ihre herstellung und verwendung
DE3038855A1 (de) * 1980-10-10 1982-05-27 Schering Ag, 1000 Berlin Und 4619 Bergkamen Neue d-homo-kortikoide, ihre herstellung und verwendung
KR960700266A (ko) * 1993-01-08 1996-01-19 클래스 빌헬름슨 신규 결장- 또는 회장-특이성 스테로이드 유도체(Novel Colon-or lleum-Specific Steroid Derivatives)
US5502222A (en) * 1994-06-01 1996-03-26 Schering Corporation Process for preparing delta 9,11 and 21-chloro corticosteroids
US8729108B2 (en) * 2008-06-17 2014-05-20 Christopher J Dannaker Waterborne topical compositions for the delivery of active ingredients such as azelaic acid

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR6682287D0 (pt) * 1965-08-30 1973-12-04 Merck & Co Inc Processo para preparar 17-alcoxi-progesteronas
NL6605514A (no) * 1966-04-25 1967-10-26
US3453297A (en) * 1968-07-24 1969-07-01 Merck & Co Inc 17alpha-lower alkoxy-pregna-4,6-diene-3,20-dione steroids

Also Published As

Publication number Publication date
DD141523A5 (de) 1980-05-07
EP0003341A2 (de) 1979-08-08
FI66023B (fi) 1984-04-30
BG33738A3 (en) 1983-04-15
SU1103797A3 (ru) 1984-07-15
PT69126A (de) 1979-02-01
SU880253A3 (ru) 1981-11-07
IL56494A (en) 1983-02-23
AU529292B2 (en) 1983-06-02
IE47729B1 (en) 1984-05-30
NO154583C (no) 1986-11-05
GB2014150B (en) 1982-11-24
IE790134L (en) 1979-07-25
NZ189460A (en) 1981-11-19
SU876059A3 (ru) 1981-10-23
FI66023C (fi) 1984-08-10
EP0003341A3 (en) 1979-08-22
PH18164A (en) 1985-04-09
EP0003341B1 (de) 1984-06-27
GB2014150A (en) 1979-08-22
FR2422689A1 (fr) 1979-11-09
NO154583B (no) 1986-07-28
DK28779A (da) 1979-07-26
DD150749A5 (de) 1981-09-16
ES477162A1 (es) 1979-07-01
AU4365779A (en) 1979-08-02
SU890979A3 (ru) 1981-12-15
SU927123A3 (ru) 1982-05-07
BG33735A3 (bg) 1983-04-15
RO81116A (ro) 1983-06-01
US4207316A (en) 1980-06-10
EG14273A (en) 1984-06-30
FI790240A (fi) 1979-07-26
BG33737A3 (en) 1983-04-15
IL56494A0 (en) 1979-03-12
DE2967070D1 (en) 1984-08-02
BG33736A3 (en) 1983-04-15
SU876060A3 (ru) 1981-10-23
RO81116B (ro) 1983-05-30
CS207753B2 (en) 1981-08-31
RO76163A (ro) 1981-08-17

Similar Documents

Publication Publication Date Title
NO792787L (no) Fremgangsmaate ved fremstilling av antiinflammatorisk aktive 4,5-diaryl-2-nitroimidazoler
NO801155L (no) Fremgangsmaate ved fremstilling av acyl-carnitinamider
NO790358L (no) Fremgangsmaate for fremstilling av alkylendiaminderivater
NO792760L (no) Fremgangsmaate ved fremstilling av nye nafthydrinderivater
NO794010L (no) Fremgangsmaate ved fremstilling av aminosyrederivater
NO148281C (no) Fremgangsmaate ved fremstilling av allergenholdige forbindelser
NO791831L (no) Fremgangsmaate for fremstilling av aminotiazoler
NO792823L (no) Fremgangsmaate ved fremstilling av nye arginiamidderivater
NO802913L (no) Fremgangsmaate ved fremstilling av cephalosporinforbindelse
ES494635A0 (es) Procedimiento de preparacion de derivados de tiadiazol
NO792500L (no) Fremgangsmaate for fremstilling av stivelseholdige naeringsmidler
NO794069L (no) Fremgangsmaate ved fremstilling av terapeutisk virksomme imidayolderivater.
NO792474L (no) Fremgangsmaate ved fremstilling av indanyl-derivater
NO792404L (no) Fremgangsmaate for fremstilling av imidazolderivater
NO150155C (no) Fremgangsmaate for fremstilling av 2-pyrrolidon-forbindelser
NO149957C (no) Fremgangsmaate for fremstilling av 4-(6`-metoksy-2`-naftyl)butan-2-on.
NO150156C (no) Fremgangsmaate ved fremstilling av 5(6)-thio-benzimidazolderivater
DK260579A (da) Fremgangsmaade til fremstilling af 14,15-methylenderivater af oestranraekken
NO150799C (no) Fremgangsmaate for fremstilling av lysergol-derivater
FI793367A (fi) Foerfarande foer framstaellning av 1,2,3-tiadiazol-5-yl-urinaemnen
NO146656C (no) Fremgangsmaate ved fremstilling av xylitolholdige drops
DK173379A (da) Fremgangsmaade til fremstilling af 6alfa-halogen-3-keto-delta 1,4-pregnadienderivater
NO801982L (no) Fremgangsmaate ved fremstilling av svovelholdige isokinolinderivater
NO791458L (no) Fremgangsmaate til fremstilling av 1,2-dikloretan
NO790229L (no) Fremgangsmaate ved fremstilling av 11beta-hydroxysteroider av pregnanrekken som er substituert i 17-stilling